Daniel Raynor is Director at ANI PHARMACEUTICALS INC (ANIP). They have made 11 open-market trades across 2 companies since 2006, most recently 2018-03-19.
CIK 0001068854
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL | 2018-03-15 | 2018-03-19 | $60.75 | $761K | -3.6% | +2.0% | +10.9% |
| ANIP | SELL | 2018-03-12 | 2018-03-14 | $62.39 | $2.6M | -5.0% | -4.2% | +8.2% |
| ANIP | SELL | 2015-03-12 | 2015-03-16 | $63.00 | $12.6M | -18.3% | -1.0% | -1.0% |
| ANIP | SELL | 2014-03-14 | 2014-03-18 | $33.85 | $418K | -18.3% | -1.0% | -1.0% |
| ANIP | SELL | 2014-03-12 | 2014-03-14 | $33.89 | $715K | -18.3% | -1.0% | -1.0% |
| ANIP | SELL | 2014-03-12 | 2014-03-18 | $33.89 | $716K | -18.3% | -1.0% | -1.0% |
| NUCO | SELL | 2006-08-24 | 2006-08-28 | $26.14 | $105K | N/A | N/A | N/A |
| NUCO | SELL | 2006-08-21 | 2006-08-23 | $26.64 | $80K | N/A | N/A | N/A |
| NUCO | SELL | 2006-05-22 | 2006-06-07 | $26.50 | $80K | N/A | N/A | N/A |
| NUCO | SELL | 2006-02-23 | 2006-02-27 | $28.61 | $57K | N/A | N/A | N/A |
| NUCO | SELL | 2006-02-10 | 2006-02-13 | $29.45 | $165K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.